Showing results (221-230 of 716) with videos related to
Sort By:
Pageof 72
Leukemia & Lymphoma|June 13, 2025
Effectiveness of olutasidenib versus ivosidenib in patients with mutated isocitrate dehydrogenase 1 acute myeloid leukemia who are relapsed or refractory to venetoclax: the 2102-HEM-101 trial versus a US electronic health record-based external control armCatherine E Lai, Thomas P Leahy, Alex J Turner, et al.Cancer Chemotherapy and Pharmacology|November 27, 2002
Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemiaJorge Cortes, Apostolia M Tsimberidou, Ricardo Alvarez, et al.Blood|May 22, 2008
Failure to achieve a major cytogenetic response by 12 months defines inadequate response in patients receiving nilotinib or dasatinib as second or subsequent line therapy for chronic myeloid leukemiaConstantine S Tam, Hagop Kantarjian, Guillermo Garcia-Manero, et al.Journal of the Korean Association of Oral and Maxillofacial Surgeons|June 28, 2024
An unusual presentation of peripheral ameloblastoma in the maxillaRosa María Acevedo Ocaña, Jorge Cortes-Bretón Brinkmann, Carolina Valle Rodríguez, et al.Blood|March 21, 2012
EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experienceElias Jabbour, Jorge Cortes, Aziz Nazha, et al.Leukemia Research|May 4, 2004
Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: complete cytogenetic response with imatinib mesylate: report of a case and review of the literatureApostolia-Maria Tsimberidou, Jorge Medina, Jorge Cortes, et al.Clinical Lymphoma, Myeloma & Leukemia|December 26, 2012
Azacitidine in fludarabine-refractory chronic lymphocytic leukemia: a phase II studyAsifa Malik, Mahran Shoukier, Guillermo Garcia-Manero, et al.Journal of Hematology & Oncology|March 17, 2018
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosisHans Michael Kvasnicka, Jürgen Thiele, Carlos E Bueso-Ramos, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 5, 2015
Pharmacokinetics of posaconazole prophylaxis of patients with acute myeloid leukemiaGloria Mattiuzzi, Musa Yilmaz, Hagop Kantarjian, et al.Blood|March 7, 2008
The effects of imatinib on pregnancy outcomeSeonaid M Pye, Jorge Cortes, Patricia Ault, et al.Pageof 72